Affordable Access

Access to the full text

Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral Infection

Authors
  • Bailey, Alison L.1
  • Al-Adwan, Saif2
  • Sneij, Eliea3
  • Campbell, Nicholas3
  • Wiisanen, Matthew E.1
  • 1 Centennial Heart at Parkridge, HCA Healthcare, 2205 McCallie Avenue, Chattanooga, TN, 37404, USA , Chattanooga (United States)
  • 2 Erlanger Heart and Lung Institute/University of Tennessee College of Medicine Chattanooga, Chattanooga, TN, USA , Chattanooga (United States)
  • 3 University of Tennessee College of Medicine Chattanooga, Chattanooga, TN, USA , Chattanooga (United States)
Type
Published Article
Journal
Current Cardiology Reports
Publisher
Springer-Verlag
Publication Date
Apr 06, 2021
Volume
23
Issue
5
Identifiers
DOI: 10.1007/s11886-021-01475-6
Source
Springer Nature
Keywords
License
Yellow

Abstract

Purpose of ReviewHepatitis C virus (HCV) and atherosclerotic cardiovascular disease (ASCVD) are two diseases that affect millions around the globe. Hepatitis C affects more than 70 million individuals globally. ASCVD is commonly encountered and remains the top cause of death worldwide. A link has been identified between HCV and atherosclerosis.Recent FindingsA review of recent studies which define the association between HCV infection and an increased risk of subclinical ASCVD and experiencing cardiovascular (CV) events.SummaryIt is now recognized that there is an increased burden of atherosclerosis in individuals infected with HCV that translates into increased cardiovascular events. An increase in the number of diagnosed cases of HCV is expected as screening recommendations for the virus have expanded. Strategies to educate healthcare professionals about this increased CV risk will need to be considered as well as the optimal strategy to lower CV risk in this growing population.

Report this publication

Statistics

Seen <100 times